CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock [Member]	Common Stock [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Common Stock [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Additional Paid-in Capital [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Accumulated Deficit [Member]	Accumulated Deficit [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Accumulated Deficit [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Other Comprehensive Loss [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Accumulated Other Comprehensive Loss [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Treasury Stock [Member]	Treasury Stock [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Treasury Stock [Member] Cumulative Effect, Period of Adoption, Adjusted Balance [Member]	Total	Cumulative Effect, Period of Adoption, Adjustment [Member]	Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Balance at Dec. 31, 2021	$ 23			$ 80,708			$ (54,584)			$ (104)			$ (2,999)			$ 23,043
Balance (in shares) at Dec. 31, 2021	2,253,000
Balance (in shares) at Dec. 31, 2021													(160,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]								ASC 326 [Member]	ASC 326 [Member]
Stock-based compensation expense	$ 0			1,859			0			0			$ 0			1,859
Common stock issued for RSUs vested	$ 1			(1)			0			0			0			0
Common stock issued for RSUs vested (in shares)	53,000
Shares withheld to pay taxes	$ 0			(263)			0			0			0			(263)
Foreign currency translation adjustment	0			0			0			110			0			110
Repayment of convertible note in shares	$ 1			824			0			0			0			825
Repayment of convertible note in shares (in shares)	99,000
Net loss	$ 0			0			(15,343)			0			0			(15,343)
Balance at Dec. 31, 2022	$ 24	$ 0	$ 24	83,127	$ 0	$ 83,127	(69,927)	$ (57)	$ (69,984)	6	$ 0	$ 6	$ (2,999)	$ 0	$ (2,999)	$ 10,231	$ (57)	$ 10,174
Balance (in shares) at Dec. 31, 2022	2,405,000	0	2,405,000													2,404,681
Balance (in shares) at Dec. 31, 2022													(160,000)	0	(160,000)	(159,891)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0			1,168			0			0			$ 0			$ 1,168
Common stock issued for RSUs vested	$ 1			(1)			0			0			0			0
Common stock issued for RSUs vested (in shares)	98,000
Shares withheld to pay taxes	$ 0			(190)			0			0			0			(190)
Foreign currency translation adjustment	0			0			0			28			0			28
Repayment of convertible note in shares	$ 7			2,879			0			0			0			2,886
Repayment of convertible note in shares (in shares)	691,000
Net loss	$ 0			0			(8,724)			0			0			(8,724)
Balance at Dec. 31, 2023	$ 32			$ 86,983			$ (78,708)			$ 34			$ (2,999)			$ 5,342
Balance (in shares) at Dec. 31, 2023	3,194,000															3,194,030
Balance (in shares) at Dec. 31, 2023													(160,000)			(159,891)